Literature DB >> 12568782

Toxicokinetics in preclinical evaluation.

Paul Baldrick1.   

Abstract

Toxicokinetic evaluation is both a regulatory and scientific requirement in the drug development process. However, as a fairly new term, its use within the industry is still confused. Toxicokinetics is the generation of kinetic data to assess systemic exposure, either as an integral component of preclinical toxicity studies, or in specially designed supportive studies. These data help to understand the relationship between observed toxicity and administered dose. They also play a role in the clinical setting, assisting in the setting of plasma limits for early human exposure and in the calculation of safety margins.

Entities:  

Mesh:

Year:  2003        PMID: 12568782     DOI: 10.1016/s1359-6446(02)02568-0

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  2 in total

1.  MEGen: A Physiologically Based Pharmacokinetic Model Generator.

Authors:  George Loizou; Alex Hogg
Journal:  Front Pharmacol       Date:  2011-11-10       Impact factor: 5.810

2.  Bioanalysis in drug discovery and development.

Authors:  Saurabh Pandey; Preeti Pandey; Gaurav Tiwari; Ruchi Tiwari
Journal:  Pharm Methods       Date:  2010-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.